Filing Details
- Accession Number:
- 0001209191-21-046071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-08 19:49:19
- Reporting Period:
- 2021-07-07
- Accepted Time:
- 2021-07-08 19:49:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1801777 | Applied Molecular Transport Inc. | AMTI | Pharmaceutical Preparations (2834) | 814481426 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1813423 | Bittoo Kanwar | C/O Applied Molecular Transport Inc. 1 Tower Place, Suite 850 South San Francisco CA 94080 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-07-07 | 7,500 | $2.38 | 7,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-07-07 | 6,651 | $42.01 | 849 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-07-07 | 800 | $42.67 | 49 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-07-07 | 49 | $43.84 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-07-07 | 7,500 | $0.00 | 7,500 | $2.38 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
135,672 | 2029-04-26 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on January 28, 2021.
- The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.53 to $42.51, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.58 to $42.73, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- 1/4th of the shares subject to the option became vested and exercisable on April 22, 2020 and 1/48th of the shares subject to the option continue to vest each month thereafter, provided that reporting person is a service provider to the issuer as of each such vesting date.